Table 1.
Treatment | Mounts | Mount Latency (secs.) |
Intromissions | Introm. Latency (secs) |
Ejaculations | Ejaculation Latency (secs) |
---|---|---|---|---|---|---|
Control | 10.9 ± 1.36 | 831.2 ± 196.1 | 9.9 ± 3.54 | 1093±160.8 | 0.6 ± 0.25 | 1693±58.32 |
RFRP-3 (500 ng) |
2.1 ± 0.83a | 1260 ± 183.9 | 1.7 ± 0.81 a | 1484±149.5 | 0.1 ± 0.08 a | 1726±73.79 |
RFRP-3 (100 ng) |
9.5 ± 1.03 | 910 ± 83.1 | 8.5 ± 0.1.33 | 1142 ± 33.1 | 0.5 ± 0.42 | 1733± 121.3 |
Anti-RFRP-3 | 17.5 ± 1.13 a | 411.1 ± 57.8 a | 15.1 ± 4.32 a | 787±121.8 a | 0.8 ± 0.02 | 1577±122.11 |
Letter indicates statistical difference from Control group (p < 0.01).
Data presented as means ± SEM.